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Abstract
Objectives: The associations of the insertion-deletion angiotensin-converting enzyme (I/D ACE) genetic 
polymorphism with the risk of preeclampsia development were studied. Materials and Methods: The study group 
included 350 women: 100 women with a physiological pregnancy and 250 pregnant women with preeclampsia. 
All women underwent the typing of I/D polymorphism of the ACE gene. Results: The pregnant women with 
the preeclampsia of the 2nd degree of severity showed the lowest concentration of genotype II ACE (11.00%) as 
compared with pregnant women without preeclampsia (25.00%; odds ratio [OR] = 0.37; P = 0.017; Pcor = 0.051). 
With the preeclampsia of the 3rd degree of severity, the minimum frequency of the genotype II ACE (7.27%) and 
the maximum frequency of the allele D ACE (62.73%) are recorded among pregnant women as compared with the 
pregnant women without preeclampsia (25.00%; OR = 0.24; P = 0.01; Pcor = 0.03 and 49.50%, OR = 1.72, P = 0.03, 
respectively). Conclusions: Thus, the D ACE allele is associated with the risk of preeclampsia development of the 
3rd degree of severity, and the ACE genotype II is a protective factor of preeclampsia development of the 2nd and 
the 3rd degree of severity.
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INTRODUCTION
Preeclampsia is the pregnancy complication that occurs in the second half of it, and characterized by the appearance of 
edema, proteinuria, hypertension, and profound 
disabilities of the vascular system function, 
hemostasis, immunity, hemodynamics, 
and microcirculation, the development of 
fetoplacental insufficiency, renal, liver, and lung 
dysfunction.[1,2] According to the literature data, 
the frequency of preeclampsia makes 4-18% 
among all pregnant women.[3] Preeclampsia 
is the major cause of preterm labor onset, the 
premature detachment of properly located 
placentae, intrauterine growth retardation, and 
the low birth weight among infants.[4]
In the preeclampsia pathogenesis, an important 
role is provided to vascular reactions, which are 
based on generalized vasospasm, conditioning 
the ischemic, and hypoxic changes in the tissues with the 
violation of their functions.[5] Renin-angiotensin-aldosterone 
system plays an important role in the functioning of a 
cardiovascular system, particularly angiotensin-converting 
enzyme (ACE) hydrolyzing angiotensin I into angiotensin II 
which is a potent vasoconstrictor.[6,7]
One of ACE gene well-studied polymorphisms is the 
presence or absence (insertion/deletion [I/D] ACE) of 287 bp 
fragment in the 16th gene intron.[8] This polymorphism is not 
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structural, but apparently it affects the degree of this gene 
expression. This is confirmed by several studies in which it 
was shown that healthy individuals with DD genotype have 
maximum level of ACE in blood, people with the II genotype 
have decreased ACE level (in 2 times) and heterozygotes 
have intermediate blood enzyme level.[8-10]
The available data on the relationship between the 
polymorphism of ACE gene and the risk of preeclampsia 
development are contradictory.[11-20]
In this regard, further research is needed to study the role of 
I/D ACE locus in the development of this complication of 
pregnancy.
MATERIALS AND METHODS
Object of study
The study group included 350 women: 250 pregnant women 
with preeclampsia and 100 women with normal pregnancy. 
The samples under study included the individuals of Russian 
nationality who were born in the Central Black Earth region 
of Russia and did not have any kinship. The average age of 
pregnant women with preeclampsia was 27.11 ± 6.42 years 
(it varied from 18 to 44 years), the control group age was 
26.50 ± 6.36 years (the age varied from 18 to 42 years) 
(P > 0.05). Clinical and laboratory examination of pregnant 
women was carried out at the time of delivery on the basis 
of the Perinatal Center of the Belgorod Regional Clinical 
Hospital of St. Joasaph.
Among 350 pregnant women, 100 patients had a 
physiological course of gestation and 250 women with 
the pregnancy complicated by preeclampsia: 95 pregnant 
women with preeclampsia of the 1st degree of severity, 100 
with the preeclampsia of the 2nd degree of severity, and 
55 with the preeclampsia of the 3rd degree of severity. 
Preeclampsia was defined as the presence of hypertension, 
accompanied by proteinuria, as defined by a 24 h urine 
protein excretion more than 300 mg (ACOG Committee 
on Practice Bulletins-Obstetrics, 2002).[1] The degree of 
preeclampsia severity was assessed by Goecke scale in the 
modification by Savelieva.[21]
Molecular and genetic methods
All women underwent the typing of I/D polymorphism of the 
ACE gene.
The material for the study was venous blood in the volume 
of 8-9 ml, taken from the ulnar vein of the proband. The 
isolation of genomic DNA from peripheral blood was 
carried out by the phenol-chloroform extraction method.[22] 
The locus analysis was performed by polymerase chain 
reaction of DNA synthesis. The genotyping of the DNA 
marker was performed by the methods of polymorphism 
analysis concerning the lengths of amplified fragments 
(I/D ACE).
Statistical methods
The development of the database and the statistical 
calculations were carried out using the program 
“STATISTICA 6.0.” To assess the compliance of the observed 
distribution of genotypes with an expected one, the criterion 
χ2 was used, based on the Hardy–Weinberg equilibrium. 
The associations of the alleles and the genotypes of the 
studied DNA markers with preeclampsia were evaluated by 
the analysis of 2 × 2 contingency tables with the calculation 
of the χ2 criterion using the Yates correction for continuity 
and the odds ratio (OR) with 95% confidence interval. 
Bonferroni amendment was used during the performance of 
multiple comparisons.[23]
RESULTS
The study showed that there is the tendency to increase the 
concentration of the D allele of the I/D ACE locus (56.80%) 
among the pregnant women with preeclampsia in comparison 
with the pregnant ones of the control group (49.50%), but 
these differences do not reach a statistically significant level 
(P = 0.10) [Table 1].
The analysis of genotype and allele frequency distribution of 
I/D ACE in the groups of pregnant women with preeclampsia 
with various severity and in the control group showed that 
the pregnant women with the preeclampsia of the 2nd severity 
level had the lowest concentration of genotype II ACE 
(11.00%) (25.00%; χ2 = 5.73; OR = 0.37; 95% CI: 1.18-6.29; 
P = 0.017; Pcor = 0.051) [Table 2].
At the preeclampsia of the 3rd degree of severity, the minimum 
frequency of genotype II ACE (7.27%) [Table 2] and the 
maximum diffusion of D ACE allele (62.73%) are recorded 
among pregnant women, as compared with pregnant women 
without preeclampsia (25.00%; χ2 = 6.21; OR = 0.24, 95% 
CI: 1.29-15.39, P = 0.01, Pcor = 0.03 and 49.50%, χ
2 = 4.48, 
OR = 1.72, 95% CI: 1.04-2.84, P = 0.03, respectively).
DISCUSSION
The data obtained from the study indicate that the genetic 
polymorphism of the I/D ACE is associated with the severity 
of preeclampsia. In this work, they found that the formation of 
preeclampsia of the 2nd degree of severity is associated with 
the genetic variants of II ACE (OR = 0.37), and preeclampsia 
of the 3rd degree is associated with D ACE (OR = 1.72), and 
II ACE (OR = 0.24).
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According to the published data, the individuals with allele 
D of ACE gene have a higher circulating enzyme level in 
blood as compared to the carriers of the ACE genotype II, 
heterozygotes ID ACE have an intermediate level of 
enzyme.[8-10] Increased ACE activity among the people with 
DD ACE genotype leads to the increase of angiotensin II 
level in plasma, which may increase the risk of preeclampsia 
development.
The studies on the search for polymorphism associations 
I/D ACE with the risk of preeclampsia development were 
conducted in various populations of the world.
The studies performed in Iranian and Indian populations 
showed that the risk of preeclampsia development is higher 
among pregnant women with the D ACE allele.[13,15,17] In 
addition, the populations of Romania and the United States 
revealed the associations of DD ACE genotype with the 
development of preeclampsia.[12,14] Besides, the studies 
conducted in the populations of India, China, and Colombia, 
revealed no significant effect of I/D ACE on the development 
of preeclampsia.[11,16,19]
The observed inconsistency in the above results can be 
explained by interpopulation and interethnic differences 
in the distribution of the I/D polymorphism: allele D is 
predominant in Caucasians from Europe, Australia, and the 
USA, whereas allele I is more prevalent among Chinese and 
Indians.[24-27]
CONCLUSIONS
Thus, it was established that the allele D ACE is associated 
with the risk of preeclampsia development of the 3rd degree of 
severity, and the genotype II of ACE is a protective factor in 
the development of preeclampsia of the 2nd and the 3rd degree 
of severity.
SUMMARY
The results of the performed study broaden the understanding 
of the molecular genetic determinants for the development 
of preeclampsia. The obtained data can be used in the work 
Table 1: Comparative analysis of frequencies of alleles and genotypes of I/D ACE in the studied groups of 
women
Gene Allele, genotype Pregnant women with 
preeclampsia
Pregnant women without 
preeclampsia
OR (95% CI)
χ2, P
n=250 (%) n=100 (%)
n % n %
I/D ACE D 284 56,80 99 49.50 0.75 (0.53‑1.05)
2.79, 0.10I 216 43.20 101 50.50
DD 76 30.40 24 24.00 0.72 (0.41‑1.27)
1.14, 0.29
ID 132 52.80 51 51.00 0.93 (0.57‑1.52)
0.04, 0.85
II 42 16.80 25 25.00 1.65 (0.91‑2.30)
2.60, 0.11
I/D ACE: Insertion deletion angiotensin converting enzyme, OR: Odds ratio, CI: Confidence interval
Table 2: Comparative analysis of genotype frequencies of I/D ACE among pregnant women with preeclampsia 
of varying severity and in the control group
Polymorphism Pregnant 
women without 
preeclampsia (n=100)
Pregnant women with preeclampsia (n=250)
Locus Genotype Preeclampsia of 
the 1st degree of 
severity (n=95)
Preeclampsia of 
the 2nd degree of 
severity (n=100)
Preeclampsia of 
the 3rd degree of 
severity (n=55)
n % n % χ2, P n % χ2, P n % χ2, P
I/D ACE DD 24 24.00 29 30.53 χ2=0.75
P=0.39
29 29.00 χ2=0.41
P=0.52
18 32.73 χ2=0.96
P=0.33
ID 51 51.00 39 41.05 χ2=1.56
P=0.21
60 60.00 χ2=1.30
P=0.26
33 60.00 χ2=0.82
P=0.36
II 25 25.00 27 28.42 χ2=0.14
P=0.71
11 11.00 χ2=5.73
P=0.017
4 7.27 χ2=6.21
P=0.01
I/D ACE: Insertion deletion angiotensin converting enzyme
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of women’s clinics and obstetric-gynecological hospitals 
to identify the groups with pregravid preparation and early 
pregnancy groups with an increased risk of preeclampsia 
development.
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